Fezolinetant
| CAS No. | 1629229-37-3 |
|---|---|
| MDL No. | N/A |
| MF | C16H15FN6OS |
| MW | 358.40 |
| InChI Key | PPSNFPASKFYPMN-SECBINFHSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Fezolinetant is a triazolopyrazine, specifically a 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine substituted with 3-methyl-1,2,4-thiadiazol-5-yl, 4-fluorobenzoyl, and methyl groups at positions 3, 7, and 8R, respectively. It is a prescription medicine used to reduce moderate to severe vasomotor symptoms associated with menopause. It acts as a neurokinin-3 receptor antagonist and belongs to the classes of monofluorobenzenes, thiadiazoles, benzamides, and tertiary carboxamides.
| CAS No. | 1629229-37-3 |
|---|---|
| Product Name | Fezolinetant |
Biological Targets
TACR3
Associated Conditions
Hot flashes·kidney disease·liver disease
* The information provided here is compiled from public sources and is for reference only.